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Abstract
MicroRNA (miRNA) function is required for normal animal development, in particular in differentiation pathways from stem
cell and precursor populations. In neurogenesis, it is becoming increasingly appreciated that miRNAs act at many stages to
ensure proper progression. In this study we examined the role of miR-34a in neural progenitor cells (NPC) derived from
murine embryonic cortex. We found that over-expression of miR-34a in NPC significantly reduced the neuron yield upon in
vitro induction of differentiation. MiR-34a has several predicted targets in the Notch pathway, which operates to balance
progenitor self-renewal and differentiation during cortical neurogenesis. We tested several Notch pathway players for
regulation by miR-34a in undifferentiated NPC, and found that mRNA and protein levels of Numbl, a negative regulator of
Notch signaling, as well as two downstream pro-neural genes usually blocked by Notch signaling, NeuroD1 and Mash1, were
diminished, while Notch1 and Cbf1 transcripts were enhanced by miR-34a over-expression. Using a luciferase reporter assay,
we verified the Numbl 39-UTR as a direct miR-34a target. Correspondingly, knock-down of endogenous miR-34a resulted in
increased Numbl, NeuroD1 and Mash1, and reduced Notch1 transcript levels. Together these results implicate Numbl as
a physiologically relevant target of miR-34a in NPC, allowing for enhanced Notch signaling and inhibition of neuronal
differentiation. This work extends our understanding of miR-34a-mediated control of cell differentiation from cancer to
mammalian nervous system development.
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Introduction
MicroRNA (miRNA) function is essential for differentiation of
stem cells and organ morphogenesis [1,2]. MiRNAs are also
obligatory players in the orchestration of vertebrate nervous
system development [3,4,5,6]. Depletion of the miRNA-producing
enzyme Dicer in developing mouse forebrain results in microceph-
aly and perinatal death [7]. Moreover, genetic ablation of dicer
from mature cerebellar Purkinje [8] or forebrain neurons [9] is
accompanied by prominent pathology and neuronal loss. Thus it is
clear that miRNAs are critical to mature neuron integrity as well
as to neural development.
MiRNA profiling studies have defined strongly expressed brain-
enriched miRNAs and their regional localizations. For example,
miR-124a is robustly expressed throughout the brain [10], while
the miR-183-96-182 cluster is remarkable for its specific localiza-
tion to neurosensory tissue [11]. Functional studies have defined
neuro-developmental roles for some highly expressed miRNAs
such as miR-430 in brain formation [3], miR-200 family in
olfactory neurogenesis [12] and miR-124 in neuronal differenti-
ation [13,14].
In situ hybridization in zebrafish and medaka fish identified
additional miRNAs relevant to vertebrate nervous system de-
velopment [15,16]. One of these, miR-34a, was robustly expressed
in the developing CNS. MiR-34a shows conservation of the
mature miRNA sequence in human, mouse, fish, and fly,
suggesting brain developmental roles in other species. In
vertebrates the miR-34 family has three members, miR-34a, b,
an c, arising from two distinct loci (miR-34a from one locus and
miR-34b,c from a separate locus). Bommer et al. [17] assayed
mouse tissues and found miR-34a expression to be highest in the
brain, while miR-34b and c were highest in lung, but low in brain.
In mammalian profiling studies miR-34a level is generally low
throughout the body, often escaping detection. In mammalian
CNS, though miR-34a level overall is weak, several studies
indicate temporal and regional enrichment. For instance, early
multi-tissue microarray profiling in mouse placed miR-34a in
a ‘‘late-brain development’’ expression cluster [18], and sub-
sequent profiling studies in adult rodent CNS show enrichment in
cerebellum [19,20,21], medulla oblongata, spinal cord, pons [20],
and substantia nigra [21]. Sequence-based profiling in whole
mouse embryos detect miR-34a at low abundance at E9.5-11.5
[22], corresponding to onset of cortical neurogenesis. Moreover, in
situ hybridization on embryonic mouse brain tissue revealed miR-
34a signal in the progenitor cell niche surrounding the lateral
ventricle, with less expression in the cortical lamina (our un-
published observations). Together these data are consistent with
roles for miR34a in both mammalian neurogenesis and mature
neuron maintenance.
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cancer studies where their expression has been found to impact
cell cycle and apoptotic cellular pathways [23,24]. Reduction or
deletion of miR-34 is associated with higher pathologic grade and
worse prognosis of many cancers, including small lung cell cancer
[17], pancreatic cancer [25] and neuroblastoma [26,27]. Con-
versely, forced re-expression in mouse tumor models can
dramatically reduce tumor size and enhance therapies
[17,26,27]. Furthermore, miR-34a expression is regulated by
Notch and Hedgehog signaling pathways in zebrafish [28], and in
tumor cells, miR34a-c are directly induced by p53 to mediate
tumor suppressor functions [29]. The presence of miR-34a in
developing brain and its well-demonstrated role in cell cycle
control with ties to the Notch pathway, led us to investigate its role
in neural progenitor cells (NPC). We show herein that modest
elevation of miR-34a in murine NPC does not appreciably affect
NPC cell cycling, but significantly modulates expression of Notch
pathway players and counters neuronal differentiation. Moreover
we show that the Numbl 39UTR is targeted by miR-34a, and
suggest it as a primary target in NPC.
Methods
Vectors/Plasmids
Figure S1A illustrates plasmids used in this study. Shuttle
plasmids used for generating replication-deficient feline immuno-
deficiency virus (FIV)-based lentiviral vectors, and methods for
vector production are described in more detail in a previous report
[30]. For lentiviral vectors, the genomic murine miR-34a sequence
(NR_029751.1) was cloned into the 39UTR of green fluorescent
protein (GFP), or was cloned into a U6 promoter-miRNA-polyT
cassette, of the appropriate shuttle plasmid. Viral vectors were
produced by co-transfection of shuttle plasmid, packaging plasmid,
and VSV-G envelope plasmid in producing cells, according to
standard protocols in the University of Iowa Gene Transfer Vector
Core (http://www.uiowa.edu/ ˜gene/). Vectors were titered at 1–6
X1 0
8 transducing units/ml. For construction of Psicheck2
TM-
34T, forward (5’-acaaccagctaagacactgccagcggccgctat-3’) and re-
verse (5’-tggcagtgtcttagctggttgtatagcggccgc-3’) primers were an-
nealed and extended by PCR to generate 5’-acaaccagctaaga-
cactgccagcggccgctatacaaccagctaagacactgcca-3’ containing two
perfect miR-34a target sites (underlined) with complete comple-
mentary to mature miR-34a.
This product was cloned into pCR
TM2.1-TOPO (Invitrogen,
Carlsbad, CA) and sub-cloned into the 3’UTR of firefly luciferase
in Psicheck2
TM (Promega Corporation, Madison, WI). Psi-
check2
TM with Numbl target sites was generated by cloning the
entire 3’UTR of murine Numbl (bp1993–2733 of NM_010950)
into the 39UTR of firefly luciferase in Psicheck2
TM. To eliminate
Numbl miR-34 target sites, 4 bases within the seeds were mutated
using QuikChange mutagenesis (Agilent Technologies, Santa
Clara, CA), changing 5’-cactgcc-3’ to 5’-cagacgc-3’.
Animal Husbandry
C57Bl6/J mice were purchased from The Jackson Laboratory
(Bar Harbor, Maine) or bred in-house. All experiments were
approved by the University of Iowa Animal Care and Use
Committee, and procedures were performed in accordance with
those guidelines. Animals were housed in the University of Iowa
Animal Care facilities, and maintained on a 12h:12h light:dark
cycle with free access to food and water.
NPC Preparation
Timed matings were set up with one male and one to three
females co-housed in the male’s home cage from one afternoon
until the next morning. Embryonic day 0.5 (E0.5) was defined as
noon on the day the animals were separated. To prepare NPC
cultures, mouse embryos were collected at E11.5, E13.5, or
E15.5 from pregnant dams. Dams were over-anaesthetized with
0.2 ml/g of a 1% ketamine/10% xylazine mixture followed by
cervical dislocation. Embryos were rapidly removed, rinsed in
PBS with 2% glucose (PBSG) and decapitated. Brains were
removed, and whole cortex was isolated and diced, then
triturated in PBSG using cotton-stuffed sterile glass Pasteur
pipettes. The solution was transferred to 15-ml falcon tubes and
diced tissue was allowed to settle. The supernatant was trans-
ferred to a fresh tube. NPC maintenance media (Stem Cell
Technologies, Vancouver, Canada) was added to the remaining
tissue pieces, which were again triturated to dissociate more cells,
and the supernatant was transferred. This procedure was
repeated 5 times, then the remaining tissue pieces were
discarded, and the supernatant was centrifuged at 800 rpm at
4uC for 5 min. A cell pellet was easily discerned, and the clear
supernatant was discarded and replaced with ,30 ml fresh
maintenance media. Cells were seeded into T-150 filter flasks at
a density of 2 X10
6 cells/100 ml for suspension growth in tissue
culture incubators at 37uC and 5% CO2. Cells were allowed to
divide for ,5 days, forming medium-sized neurospheres. They
were then used for experiments or passaged by gentle trituration
and re-seeding in fresh maintenance media at lower density. All
cells used for experiments had been passaged six or fewer times.
Lentiviral-mediated Transduction of NPC
For NPC infections, neurospheres were gently dissociated by
trituration and 1 X 10
6 cells/well were plated in 12-well tissue
culture plates in 1 ml maintenance media and virus was added at
a multiplicity of infection (MOI) of 3. Cells were transferred to T-
25 flasks with 8 ml of NPC maintenance media 18–24 hours later
and cultured for 3 days to medium-sized neurospheres. Neuro-
spheres infected with FIVneo
rU634a or FIVneo
rU6cntrl lentiviral
vectors were selected for neomycin resistance by culturing in
maintenance media containing 500 mg/ml G418 (Invitrogen) for
3 days, then surviving cells were used directly in experiments.
NPC Differentiation
For differentiation experiments, neurospheres were dissociated
using HyQtase (HyClone, Logan, UT) for 15 min at 37uC
followed by gentle mechanical trituration. They were then
centrifuged at 1000 xg at 4uC for 5 min, then resuspended in
NPC differentiation media (Stem Cell Technologies) or IGF media
(Hyclone DMEM/F12 with addition of 1% penicillin/streptomy-
cin, 1% l-glutamine, 1% FBS, 0.3% dextrose, 20 ng/ml insulin-
like growth factor-1 (IGF-1)) (Sigma, St. Louis, MO) and seeded
into poly-L-ornithine-coated tissue culture plates or glass chamber
slides.
Secondary Neurosphere Formation Assay
E15.5-derived NPC were transduced with FIVGFP or
FIVGFP34a vectors as described above, and were mechanically
dissociated and plated at equal density in 96-well plates. After
seven days, the number of neurospheres per plate and the average
neurosphere size were measured using Image J software.
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E15.5-derived NPC were transduced with FIVneo
rU634a or
FIVneo
rU6cntrl, and selected in G418. 5-bromo-29-deoxyur-
idine/propidium iodide (BrdU/PI) cell cycle analysis (similar to
Menon et al. [31]) was performed on proliferating cells (2 and
3 days after seeding in maintenance media) and differentiating
cells at 3, 6, or 10 h after seeding dissociated cells into
polyornithine-coated dishes in differentiation media. Cells were
pulsed with BrdU (20 mM, Sigma) for 1 h prior to harvest. At
harvest, cells were dissociated with HyQtase, pelleted and
resuspended in 400 ml ice-cold PBS. Cells were fixed by addition
of 3.6 ml ice-cold 95% ethanol while vortexing, and stored
overnight at 4uC. Fixed cells were washed in PBS-TB (PBS with
0.2% tween-20 and 0.1% BSA), and resuspended in 2N HCL
with 0.5% Triton X-100 and 0.2 mg/ml pepsin (to release cell
nuclei) for 30 min at room temperature with gentle vortexing
every 5 min. Three volumes of 0.1 M sodium tetraborate were
added, nuclei pelleted and resuspended in PBS-TB and stained
with 1/500 anti-BrdU (G3G4, University of Iowa DSHB, Iowa
City, IA) for 1 h followed by 1/1500 Alexa Fluor-488-conjugated
goat anti-mouse IgG (Invitrogen) for 30 min at room tempera-
ture. Washed nuclei were resuspended in PBS containing 20 mg/
ml PI, 200 mg/ml RNaseA and 0.05% tween-20, and after
30 min incubation at room temperature were passed through 70-
mm mesh and collected on a Becton Dickinson FACScan in the
University of Iowa Flow Cytometry Facility (http://www.
healthcare.uiowa.edu/corefacilities/flowcytometry/). Ten thou-
sand to 15,000 single-nuclei events were acquired and analyzed
as dual-parameter linear PI-A vs log-Alexa 488 dot-plots.
Cellquest Pro software was used to determine cell proportions
in quadrants (UL, UR, LL, LR), with total BrdU positive
(UL+UR) representing S-phase cells, and LL and LR represent-
ing G1 and G2/M phases respectively.
Immunofluorescent Staining and Cell Counts
NPC were transduced with FIVneo
rU634a or FIVneo
rU6cntrl,
selected in G418, and differentiated as described above. After five
days, cells were fixed in 4% paraformaldehyde for 20 min at 25uC,
then blocked for 30 min in 0.05% Triton-X-100, 5% goat serum,
PBS. Primary antibody incubation proceeded at 4uC overnight.
Anti- microtubule-associated protein type 2 (anti-MAP2) (1:200,
Sigma) was used to detect neurons and anti- glial fibrillary acidic
protein-Cy3 (anti-GFAP-Cy3) (1:5000, Sigma) was used to detect
glia. Secondary antibody incubation was at 25uC for 1 hour.
Fluorescent images were captured under identical conditions for
each fluorochrome. Neurons were identified by bright MAP2
staining in the cell body and within thin projections, and negative
GFAP staining. Glial cells were identified as GFAP-bright, MAP2-
negative cells and the proportion of neurons and glia were
determined from 800 total cell counts per culture.
Measurement of Transcript Levels
Total RNA was collected from NPC or HEK293 cells using
Trizol (Invitrogen) according to the manufacturer’s instructions.
RNA quantity and quality was measured using a nanodrop ND-
1000 (Thermo Fisher Scientific, Wilmington, DE). Reverse
transcription (RT) reactions were performed using the High
Capacity cDNA Archive kit (Applied Biosystems (ABI), Foster
City, CA), with random primers for mRNAs or specific primers for
miR-34a (miR assay ID 426, ABI). Total 140 ng RNA (for
miRNA) and 200 ng RNA (for mRNA) were used in 50-mlR T
reactions. Gene expression primer-probe sets were purchased from
ABI: Numbl (assay ID: Mm00477931), Notch1 (assay ID:
Mm00435245), Cbf1 (assay ID: Mm01217626), NeuroD1 (assay
ID: Mm01200117), Mash1 (assay ID: Mm03058063) and Rpl34
(assay ID: Mm01321800). cDNA samples were used at a final
dilution of 1/45 in 20-ml quantitative PCR (qPCR) reactions
(Prism 7900HT and TaqMan 26 Universal Master Mix; ABI).
Transcript levels were determined by interpolation off of standard
curves generated from known positive samples, and Rpl34 was use
as an endogenous control for normalization.
Anti-miR Inhibition of miR-34a
100 nM or 200 nM of anti-miR miRNA inhibitor (AM11030,
ABI)) or scrambled negative control (ABI) were used for inhibition
of miR-34a in NPC. The anti-miR was added to singly dissociated
cells in suspension and electroporation was performed using the
Neon Transfection System (Invitrogen). Total RNA was harvested
72 h later with TRIzol (Invitrogen), and RT-qPCR performed as
described above.
Western Blot
NPC transduced with FIVneorU634a or FIVneorU6cntrl were
harvested in RIPA lysis buffer containing 1X protease inhibitor
(Pierce Biotechnology, Rockford, IL) using standard techniques,
and protein concentrations were determined by DC Protein Assay
(Bio-Rad, Hercules, CA). Samples were reduced and separated by
SDS-PAGE on 4%–10% acrylamide gels and transferred to
Immobilon PVDF transfer membranes (Millipore, Billerica, MA).
The primary antibodies used were as follows: Numbl (1:1000,
Abcam, Cambridge, MA), NeuroD1 (1:1000, Millipore), Mash1
(1:200, BD Biosciences Pharmingen, San Diego, CA), b-actin
(1:5000, Sigma), and b-catenin (1:5000 Abcam). Blots were
developed using ECL Plus Western Blotting Detection System
(GE Healthcare, Pittsburg, PA), images captured using VersaDoc
imaging system (Bio-Rad) and quantified by densitometric
analyisis using Quantity One software (Bio-Rad). Band densities
were normalized to house-keeping (b-actin or b-catenin) band
densities in the same lanes.
Psicheck2
TM Luciferase Assays
For luciferase assays, lentiviral vector shuttle plasmid (control or
miR-34a-expressing) and appropriate Psicheck2
TM luciferase re-
porter construct were co-transfected into HEK293 cells at a ratio
of 8 ng:1ng using lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. Lysates were collected 18–24 h after
transfection and luciferase activity was measured using the dual-
luciferase kit (Promega) according to manufacturer’s instructions,
using a Monolight 3010C Luminometer (BD Biosciences Phar-
mingen). Firefly luciferase activity was normalized to renilla
luciferase activity.
Statistics
Unless otherwise indicated in the legend, data are plotted as
mean 6 standard deviation (SD) of replicate experiments.
Statistical differences between test and control groups were
determined by Mann-Whitney rank sum test (sphere size and
BrdU/PI flow cytometry) or Student’s t test.
Results
To test our prediction that miR-34a functions in NPC, we
generated NPC from mouse embryonic cortex, and examined the
effects of miR-34a over-expression or reduction. For over-
expression, we used replication-deficient lentiviral vectors (Fig
S1a) to stably introduce a miR34a expression cassette, and for
knock-down of endogenous miR34a, we transfected with anti-miR
miRNA inhibitors. We first tested our lentiviral constructs for
miR-34 Regulates Neurogenesis
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TM
luciferase reporter system. HEK293 cells were co-transfected with
the lentiviral shuttle plasmid (miR-34a or control) and the
Psicheck2
TM plasmid encoding firefly luciferase fused to miR-
34a perfect target sites (Psicheck2
TM-34T). The miR-34a expres-
sion vectors repressed firefly luciferase activity by 50–75% (Fig.
S1b), verifying miR-34a expression and processing to the mature
functional form. The lentiviral constructs were subsequently used
for viral vector production. We verified the activities of lentiviral
vectors and anti-miR oligonucleotides in our NPC: transduction
with miR-34a-expressing lentiviral vectors increased miR-34a
levels 1.6–4.5 fold relative to control-transduced cultures, and
transfection with anti-miR lowered endogenous miR-34a levels to
approximately 20–30% of control (Fig S1c).
Next, we assessed the effect of miR34a over-expression on NPC
differentiation. NPC were established from 3 time points during
cortical neurogenesis- E11.5, E13.5, and E15.5. We effected gain
of miR-34a in cultured NPC by transducing with FIVneo
rU634a.
Control NPC were transduced with FIVneo
rU6cntrl. After
selecting in G418, NPC were plated in differentiation-promoting
conditions as detailed in Methods. Five days later, neurons and
glial cells were identified by immunofluorescent staining and
morphological criteria (Fig. 1a). A substantial difference in cell
counts indicated that this modest over-expression of miR-34a had
a potent effect on neurogenesis; neuron production from NPC
initiated at all three time points was significantly repressed relative
to control cultures (Fig. 1b).
Based on enhanced glial cell production at E11.5 and E15.5
(Fig. 1b), cellular fate shift may account for some of the neuron loss
in these cultures. However, at E13.5, neuron production was
decreased while the glial population was similar to control
cultures. We therefore tested a role for slowed cell cycling in
NPC transduced with miR-34a-encoding virus. After chemical
dissociation, miR-34a- or control-infected NPC were re-plated in
proliferation or differentiation conditions. Under proliferation
conditions, miR-34a over-expression did not change secondary
neurosphere number (Fig. 2a). Secondary neurosphere size,
however, was slightly but significantly reduced (Fig. 2b, median
Figure 1. MiR-34a over-expression in NPC reduces neuron yield upon differentiation. NPC generated from E11.5, E13.5 and E15.5 cortices
were transduced with FIVneo
rU6cntrl (control) or FIVneo
rU634a (miR-34a) and differentiated for 5 days as described in Methods. Neurons and glia
were identified by MAP2 and GFAP immunofluorescence labeling. A) Representative image after differentiation of E15.5 NPC, showing MAP2 positive
neurons (green), GFAP positive astrocytes (red), and cell nuclei (hoechst stain, blue). Arrows indicate neurons. Scale bar 100-mm. B) The percentage of
neurons and glia were determined for each culture. Data points represent the mean 6 SD percentage of neurons or glia in cultures. *p,0.05, for
neurons in miR-34 over-expressing compared to control.
doi:10.1371/journal.pone.0038562.g001
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e38562Figure 2. Cell cycle analysis. NPC established from E15.5 were infected with miR-34a-expressing or control lentiviral vectors and proliferation
parameters assessed. A and B) In non-differentiation conditions, NPC transduced with FIVGFP (control) or FIVGFP34a (miR-34a) were dissociated and
plated at low density and one week later neurospheres were counted (A, bar graphs) and sphere size measured and (B, box plots). For neurosphere
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a 1 h pulse with the thymidine analog BrdU, and cell nuclei were
subsequently extracted and analyzed by flow cytometry for BrdU
incorporation and DNA content. The distribution of cells in S-
phase (BrdU positive), G1 (BrdU negative, 2N DNA), and G2/M
(BrdU negative, 4N DNA), was not significantly affected by miR-
34a over-expression in either proliferating or differentiating (3, 6,
or 10 h post-differentiation) NPC (Fig. 2c). These results indicate
that in our system, unlike cancer cell lines, miR-34a over-
expression does not promote cell cycle exit, and therefore
progenitor depletion via premature cell cycle exit does not explain
reduced neuron counts upon differentiation.
We next turned to available target prediction software for
indication that miR-34a might work within a molecular pathway
that regulates neural differentiation. By querying targetscan.org we
noticed that several genes in the Notch pathway [32] are predicted
murine targets of miR-34, including the anti-differentiation
factors, Notch1, Notch2, and Cbf1(Rbpj), the pro-differentiation
factors Numbl and Mash1(Ascl1), and the Notch ligands Jag1 and
Dll1. Our schematic (Fig. 3a) outlines relevant components of the
canonical Notch pathway; ligand binding triggers Notch cleavage
and translocation of the Notch intracellular domain to the nucleus
where it associates with Cbf1 to activate Hes1/Hes5 transcription,
which in-turn repress expression of pro-neural genes NeuroD1,
neurog2 and Mash1. Numb/Numbl directly block Notch to prevent
signaling. Depending on which predicted targets are real and
physiologically relevant during neurogenesis, miR-34a could
promote or antagonize differentiation.
To determine the ability of miR-34a to regulate Notch
pathway players in NPC, we transduced NPC with FIV-
neo
rU634a or FIVneorU6cntrl vectors, selected the transduced
NPC by culturing in G418, and assessed mRNA levels of Numbl,
Notch1, Cbf1, NeuroD1, and Mash1. Interestingly we found that
transcript levels of Notch1 and Cbf1 were elevated in the context
of miR-34a over-expression (Fig 3b). In contrast, mRNA levels of
Numbl, NeuroD1, and Mash1 were repressed in miR-34a-over-
expressing NPC (Fig 3b). Consistent with this, down-regulation of
endogenous miR-34a by anti-miR treatment led to decrease in
Notch1 and increases in Numbl and Mash1 mRNA levels (Fig 3c).
Densitometric analysis of immunoblots indicated that changes in
protein levels upon miR34a over-expression were in agreement
with transcript data; protein levels of Numbl, NeuroD1 and
Mash1 were reduced, while Notch1 was elevated. (Fig. 3d,e).
Together, these observations provide strong evidence that miR-
34a functions to repress negative signals within the Notch
pathway and potentiate Notch1 signaling in NPC, thereby
antagonizing neuronal differentiation.
Decline in Numbl transcript and protein quantities prompted us
to evaluate Numbl as a direct miR-34a target. We therefore cloned
the murine Numbl 39UTR, which contains two predicted target
sites for miR-34a, into the Psicheck2
TM reporter plasmid and used
site-directed mutagenesis to separately ablate each target site. We
subsequently challenged these reporters with miR-34a over-
expression in HEK293 cells. Indeed, miR-34a mediated significant
repression of the luciferase reporter fused to the native Numbl
3’UTR, while mutation of the either target site abrogated
repression (Fig. 4), suggesting that the two target sites likely
cooperate to mediate miR-34a repression of Numbl. Collectively
our results show that miR34a operates as a regulator within the
Notch pathway in NPC, where it directly targets Numbl transcripts.
Discussion
In this study we generated NPC with moderate over-expression
of miR-34a, and examined the effects on subsequent differentia-
tion. Intriguingly, we found that neuronal output from these NPC
was substantially impaired. We further determined that miR-34a
expression influenced transcript and protein abundance of several
Notch pathway players in NPC, thus implicating miR34a as
a regulatory component of the Notch pathway. Moreover, we
provide novel evidence that Numbl is a direct miR-34a target.
Together these results suggest that miR-34a antagonizes neuronal
differentiation in progenitor cells at least in part by direct
repression of Numbl.
In tumor cells, miR34a-c act as p53 effectors, mediating down-
regulation of cell-cycling gene programs and promoting apoptosis
[24,25]. We thus reasoned that reduced neuron numbers in our
differentiated NPC cultures could reflect changes in the pro-
genitor cell cycle. Cell cycle progression in NPC is intimately
involved with the state of differentiation. The length of the G1
phase of the cell cycle increases during neurogenesis and is
thought to facilitate protein synthesis and integration of signals
needed for neuronal specification and differentiation [33,34].
Upon examining cell cycling parameters however, we found that
our modest over-expression of miR-34a did not significantly
change the percent self-renewing neural stem cells (measured by
sphere number) or percent cells in S, G1, G2/M (determined by
BrdU incorporation and DNA content). This coincides with
minimal effects of miR-34a over-expression in an astrocyte cell
line [35], but contrasts with the profound anti-proliferative effects
of mir-34a over-expression in various tumor cells [23]. When we
exposed NPC to differentiation conditions, control- and miR-
34a-transduced NPC showed very similar patterns of progressive
decline in BrdU incorporation and increase in the G1 population
from 3 to 10 h. Thus our data do not support accelerated cell
cycle exit as an explanation for the reduced neuron output after
differentiation.
Numb, Numbl and Notch1 are critical players in the complex
regulation of cortical neurogenesis, balancing progenitor self-
renewal, proliferation and differentiation [36,37,38]. We consid-
ered that miR-34a might influence neurogenesis via regulation of
protein expression in the Notch pathway. Interestingly we found
that miR-34a over-expression altered transcript and protein levels
of several players, in a pro-Notch signaling direction. We also
confirmed the Numbl 3’UTR as a direct target of miR-34a. Numbl
and Numb are highly related, though Numbl is less characterized.
They have many overlapping functions, and share the ability to
bind Notch to inhibit Notch signaling [36,39,40]. Asymmetrical
cell division with unequal inheritance of Numb/Numbl dictates
relative Notch1 signaling and is a key mechanism to regulate the
timing of neurogenesis [41]. Interestingly, Numbl has recently
been implicated in promoting adult neural stem cell differentia-
counts, bars represent the mean 6 SD of three independent cultures. For sphere size, data was combined from three independent cultures. Boxes
encompass 25th-75th percentile and whiskers mark 10th and 90th percentiles. *p,0.001, for miR-34a over-expressing compared to control. C) NPC
transduced with FIVneo
rU6cntrl (control) or FIVneo
rU634a (miR-34a) were BrdU-pulsed for 1 h under proliferating conditions (2 or 3 days after
passage), or were seeded into differentiation media and BrdU-pulsed at 2–3 h, 5–6 h, or 9–10 h post-seeding. Cells were collected directly after pulse
and analyzed for BrdU incorporation (A488 intensity) and DNA content (PI-A). Representative dot-plots are shown, and quadrant statistics for 3
replicate experiments are displayed on the dot-plots (mean 6SEM). The line graph illustrates the proportion of cells in S-phase (BrdU positive cells,
mean 6SEM of the three experiments). No significant differences in cell cycle distribution were determined (p.0.05 for miR-34a vs control).
doi:10.1371/journal.pone.0038562.g002
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e38562Figure 3. MiR-34a potentiates Notch pathway activity. A) Schematic depicting the Notch pathway. Ligand binding initiates Notch1 cleavage,
with release the intracellular domain (NICD). NICD translocates to the nucleus and binds to Cbf1, displacing transcriptional repressors and promoting
activator binding for induction of Hes1 and Hes5, which in-turn repress the expression of pro-neural genes. Numb and Numbl directly inhibit Notch
signaling. Dotted lines indicate predicted Notch pathway targets: Dll1, Jag1, Notch1, Notch2, Numbl, Cbf1 and Mash1. B) E15.5-derived NPC were
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maturation [42]. Thus, Numbl appears to be a critical player in
neuronal differentiation pathways and a miRNA target in
neuronal progenitor cells.
Notch1 is ubiquitously expressed across tissues and cells, and the
cellular outcome of Notch1 signaling can be pro- or anti-
proliferative depending on the cell type and the context of
additional intrinsic and extrinsic cues [38]. During mammalian
cortical neurogenesis, Notch1 signaling is believed to delay
differentiation, consistent with its transcriptional repression of
pro-neural genes such as Mash1 and NeuroD1 [43]. Numbl is
postulated to augment terminal differentiation by repressing
residual Notch1 activity in post-mitotic neuronal precursors that
have reached the cortical plate [36]. We observed enhanced Notch1
and reduced Mash1 and NeuroD1 transcript and protein levels with
miR-34a over-expression, indicating that delayed progression to
terminal differentiation may be an important contributing factor
to diminished neuron counts achieved post-differentiation. Lastly,
Notch1 signaling to precursors after late divisions plays an
instructive role in gliogenesis [44,45], and this could explain the
increased astrocyte counts encountered after differentiation of
some of our miR34a-overexpressing NPC cultures.
It was somewhat surprising that Notch1 was not repressed by
miR34a over-expression in NPC. The Notch1 3’UTR harbors
predicted miR-34 binding sites, and recent studies in cancer cell
systems show that miR-34a directly represses Notch1/2, to slow
proliferation [46] or invasiveness [47]. MiR-34a repression of
Numbl rather than Notch1 in our NPC may relate to transcript
abundance and differential miR-34a binding affinities. It is also
possible miR-34a indirectly enhances Notch1 expression through
an un-described pathway, and that within NPC, this indirect
enhancement dominates over direct repression.
Interestingly, recent studies [48,49] showed that endogenous
miR-34a expression rose dramatically during in vitro differentia-
tion of neural stem cells, to peak on day 6, and that miR-34a over-
expression during differentiation enhanced neuronal output and
neurite length. Their findings in combination with ours suggest
that miR-34a may counter differentiation in progenitors, but that
as differentiation proceeds miR34a escalates to potentiate matu-
ration and stabilize neuronal status. Thus miR-34a may act on
distinct targets in temporal fashion in accordance with expression
levels and target availability, to regulate progenitor self-renewal
and fine-tune differentiation kinetics.
Numb has recently been shown to modulate p53 levels by
shielding it from ubiquitination and degradation [50]. Moreover,
p53 has been shown to induce expression of Notch1 [51] in
addition to miR-34a [25] in cancer cells. In the context of NPC,
we have revealed Numbl as a direct miR-34a target, possibly
operating within a p53-Notch interconnected pathway to balance
proliferation and differentiation. Continued exploration will
address important questions regarding miR34a regulation of other
predicted targets within the p53-Notch axis and potential impact
on CNS developmental programs.
transduced with FIVneo
rU6cntrl (control) or FIVneo
rU634a (miR-34a) lentiviral vectors and RNA was collected and transcript levels determined by RT-
qPCR for Notch pathway genes. Results show transcript abundance in miR-34a over-expressing relative to control NPC (control set to 1, horizontal
line). Bars represent the mean 6 SD of three cultures. *p,0.05, **p,0.01, ***p,0.005, relative to control. C) NPC generated from E15.5 were
transfected with 100 nM anti-miR oligonulceotides targeting miR-34a or negative control oligonucleotides. RNA was collected 72 h post-transfection
and relative transcript abundance determined from three separate experiments as described in B.* p,0.05, **p,0.01, relative to control. D and E) NPC
were generated and infected as described in B, and cell lysates analyzed by Western blot. D) Representative immunoblots for Numbl, NeuroD1, and
Mash1. E) Protein abundance was determined by densitometric analysis of immunoblot bands and normalization to a housekeeping protein (either b-
actin or b-catenin). Results show mean 6 SD relative to control NPC (control set to 1, horizontal line) of three separate cultures. *p,0.05, **p,0.01,
relative to control.
doi:10.1371/journal.pone.0038562.g003
Figure 4. Numbl is a direct target of miR-34a. HEK293 cells were co-transfected with the miR-34a-expressing shuttle plasmid (FIVGFP34a) and
Psicheck2
TM-34T (with two miR-34a perfect target sites), or Psicheck2
TM with the Numbl 3’UTR, or the Numbl 3’UTR mutated in the first or second miR-
34 binding site, cloned 3’ of the firefly luciferase coding region. Luciferase assay was used to quantify miR-34a-dependent repression of firefly
luciferase. Bars show the mean 6 SD of 2 (perfect target) or 3 experiments. *p,0.05, **p,0.005, luciferase activity compared to control. NS, not
significant.
doi:10.1371/journal.pone.0038562.g004
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Figure S1 Verification of plasmids, lentiviral vectors
and anti-miR. A) Depictions of constructs used in this study.
FIV (feline immunodeficiency virus) shuttle plasmids were used to
produce replication-deficient FIV-based lentiviral vectors, and in
some experiments were used directly in transfections as expression
plasmids. Abbreviations in construct names: CMV, cytomegalo-
virus immediate early promoter; GFP, green fluorescent protein;
U6, U6 promoter; LTR, long terminal repeat region of FIV; neor,
neomycin resistance gene; 34a, miR-34a gene sequence; cntrl,
scrambled control sequence; 34T, perfect target sequence for
mature miR-34a binding; Rluc, renilla luciferase; FFluc, firefly
luciferase; pA, polyadenylation sequence. B) Shuttle plasmids were
tested for expression of functional miR-34a by co-transfection with
Psicheck2TM-34T in HEK293 cells and measurement of
luciferase activity. Bars show the mean 6 SD of three to five
experiments. *p,0.0001 for luciferase activity in cultures with
miR-34a-expressing plasmids (FIVGFP-34a or FIVGFPU634a)
compared to control plasmid (FIVGFP). C) Lentiviral vectors and
anti-miR34a oligonucleotides were tested for function in NPC.
NPC were transduced with the indicated miR-34-expressing
lentiviral vector its control counterpart. RNA was isolated and
relative levels of mature miR-34a quantified by RT-qPCR, and
are expressed relative to the respective control (control set to 1,
horizontal bar). To test anti-miR, E15.5-derived NPC were
transfected with anti-miR34a oligonucleotides or negative control
oligonucleotides. RNA was isolated after 72 h and mature miR-
34a was quantified by RT-qPCR, and is expressed relative to the
respective control (control set to 1, horizontal bar). Results show
the mean 6 SD of three or four experiments. *p,0.05,
**p#0.0001 compared to control.
(TIF)
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